United States· US:0143-9094_fd057210-bc2c-44d5-bf5d-b1f0a408a946

Methylene blue

A medicinal product containing methylene blue, registered in United States by Hikma Pharmaceuticals USA Inc..

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedMethylene blueATC—REGISTER NO.US:0143-9094_fd057210…PACKS LISTED2CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
METHYLENE BLUE
Manufacturer
Hikma Pharmaceuticals USA Inc.
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    0143-9094-05
  • ndc11
    0143909405
    5 VIAL, SINGLE-DOSE in 1 CARTON (0143-9094-05) / 10 mL in 1 VIAL, SINGLE-DOSE (0143-9094-01)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Methylene blue in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All methylene blue products

Authorised across Europe · EMA

The same active substance is authorised in 6 EEA countries. Names it is sold under:

  • Belgium · Metiblo
  • United Kingdom (Northern Ireland) · Methylthioninium Chloride Phebra Limited
  • Iceland · Proveblue
  • Italy · Metiltioninio Cloruro Bioindustria L.I.M., Metiltioninio Cloruro Monico
  • Liechtenstein · Proveblue
  • Norway · Proveblue

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b3211898-1ffc-4596-8b2c-b446e5d90284
GET /v1/drugs/b3211898-1ffc-4596-8b2c-b446e5d90284?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "INTRAVENOUS",
  "source": "ndc",
  "strength": "5",
  "substance": "METHYLENE BLUE",
  "productndc": "0143-9094",
  "dosage_form": "INJECTION, SOLUTION",
  "dea_schedule": null,
  "strength_unit": "mg/mL",
  "application_number": "ANDA216959",
  "marketing_category": "ANDA"
}

See everything about methylene blue.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.